Results 11 to 20 of about 23,620 (204)

Therapeutic Efficacy of Orally Administered Nitrofurantoin against Animal African Trypanosomosis Caused by Trypanosoma congolense Infection

Pathogens, 2022
Animal African trypanosomosis (AAT) leads to emaciation and low productivity in infected animals. Only six drugs are commercially available against AAT; they have severe side effects and face parasite resistance.
Keisuke Suganuma, David D. N’Da, Ken-ichi Watanabe, Yusuke Tanaka, Ehab Mossaad, Afraa Elata, Noboru Inoue, Shin-ichiro Kawazu   +7 more
doaj   +2 more sources

Antibiotic Use for Cystitis and Risk of Treatment Failure in Pregnancy Following Gastric Bypass: A Cohort Study. [PDF]

Basic Clin Pharmacol Toxicol
ABSTRACT Cystitis is common during pregnancy and requires effective antibiotic treatment to prevent complications. Gastric bypass surgery alters gastrointestinal anatomy and may impair oral drug absorption, raising concerns about antibiotic effectiveness.
Thunbo MØ, Kolding L, Azuz S, Kamronn TM, Høimark L, Pedersen LH.   +5 more
europepmc   +2 more sources

Nitrofurantoin Failure in Elderly Men: A Retrospective Observational Study [PDF]

Antibiotics, 2020
Urinary tract infections in the elderly are common. Treatment with nitrofurantoin in men may not be sufficient if concomitant tissue involvement is present, resulting in treatment failure.
Ilse Wolterink, Theo Verheij, Tamara Platteel, Ann van den Bruel, Arjen Stam, Alma van de Pol   +5 more
doaj   +4 more sources

Antibiotic Susceptibility Pattern of Urinary Isolates of Escherichia coli with focus on Fosfomycin and Nitrofurantoin

Journal of Pure and Applied Microbiology
Urinary tract infections (UTIs) are primarily attributed to Gram-negative bacteria (GNB), especially Escherichia coli, which is the most prevalent pathogen.
Anamika Vyas, Priyanshi Tripathi, Monika Advani   +2 more
doaj   +2 more sources

High-level nitrofurantoin resistance in a clinical isolate of Klebsiella pneumoniae: a comparative genomics and metabolomics analysis [PDF]

mSystems
Nitrofurantoin is a commonly used chemotherapeutic agent in the treatment of uncomplicated urinary tract infections caused by the problematic multidrug resistant Gram-negative pathogen Klebsiella pneumoniae.
Maytham Hussein, Zetao Sun, Jane Hawkey, Rafah Allobawi, Louise M. Judd, Vincenzo Carbone, Rajnikant Sharma, Varsha Thombare, Mark Baker, Gauri G. Rao, Jian Li, Kathryn E. Holt, Tony Velkov   +12 more
doaj   +3 more sources

Role of Old Antibiotics in the Era of Antibiotic Resistance. Highlighted Nitrofurantoin for the Treatment of Lower Urinary Tract Infections

Antibiotics, 2014
Bacterial infections caused by antibiotic-resistant isolates have become a major health problem in recent years, since they are very difficult to treat, leading to an increase in morbidity and mortality.
Maria Jose Munoz-Davila
exaly   +3 more sources

Reversible interstitial lung disease with prolonged use of nitrofurantoin: Do the benefits outweigh the risks?

Lung India, 2013
We describe the case summary of a 70-year-old man diagnosed with interstitial lung disease due to prolonged nitrofurantoin therapy. Despite honeycombing confirmed by computed tomography of the thorax, symptoms and radiographic findings disappeared within
Akashdeep Singh, Parminder Singh, U S Sidhu   +2 more
doaj   +2 more sources

Consider Nitrofurantoin as a Cause of Lung Injury [PDF]

European Journal of Case Reports in Internal Medicine, 2019
Nitrofurantoin-induced diffuse lung toxicity is well documented in the literature but is often misdiagnosed. We describe an 82-year-old female medicated with nitrofurantoin for the previous 2 years who was admitted for dyspnoea, dry cough and fatigue for
Paulo Almeida, Eduarda Seixas, Beatriz Pinheiro, Pedro Ferreira, Ana Araújo   +4 more
doaj   +2 more sources

Differentiating probable nitrofurantoin-induced drug fever from antipsychotic-induced hyperthermia in a patient receiving clozapine [PDF]

Mental Health Clinician, 2022
Nitrofurantoin (NIT) is a commonly utilized antibiotic for the treatment of UTIs. Although well tolerated, NIT is not without potential adverse reactions.
Stephen B. Vickery, PharmD, BCPS, Andrew D. Burch, PharmD Candidate, P. Brittany Vickery, PharmD, BCPS, BCPP, CPP   +2 more
doaj   +1 more source

Switching nitrofurantoin polymorphic outcome in solvent mediated phase transformation and crystallization using solvent and additives [PDF]

, 2023
We demonstrate that several additives and solvents allow switching the polymorphic outcome of solvent mediated phase transformation experiments and crystallization of the antibacterial drug nitrofurantoin.
Agris, Bērziņš, Sergey, Belyakov, Joop H., ter Horst, Aija, Trimdale-Deksne   +3 more
core   +2 more sources